LEO Pharma A/S In-Licenses Promising Compound From Virobay Inc. for Oral ... - MarketWatch (press release)

LEO Pharma A/S In-Licenses Promising Compound From Virobay Inc. for spoken ... MarketWatch (press release) The pharmaceutical company Lion Pharma A/S has autographed an in-licensing deal with the US biotech establishment Virobay Inc. to develop an oral treatment for psoriasis . The in-licensing deal concerns an forward-looking compound which has the potential to be the first ... and more » Link To Article